Pharma Journalist -

Lannett Company, Inc. announced that it has entered into a settlement and license agreement with Celgene Corporation that resolves patent infringement litigation in the U.S. related to…
Read More...

Xynomic Pharma announced that it has acquired exclusive global rights to develop, manufacture and commercialize BI 882370, a 2nd-generation RAF inhibitor, from Boehringer Ingelheim, a…
Read More...

SMi Reports: SMi’s 2nd annual Drug Discovery conference,taking place in London on 21st and 22nd March 2018, will discuss the role of artificial intelligence in drug discovery ‘The…
Read More...

Social Media in the Pharmaceutical Industry will address questions on how to engage patients with an effective social media strategy,look into understanding behavioural and emotional…
Read More...

SMi are thrilled to welcome Dr. Noreen Roth Henig, Chief Medical Officer, ProQR Therapeutics onto the speaker panel RNA Therapeutics 2018! ProQR is dedicated to discovering and…
Read More...

Evotec AG and TESARO, Inc. announced a three-year integrated drug discovery collaboration to discover and develop novel small molecule product candidates against an undisclosed…
Read More...

BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted valoctocogene roxaparvovec (formerly BMN 270) Breakthrough Therapy Designation. The FDA's…
Read More...

PDL BioPharma announced that it has submitted a proposal to acquire Neos Therapeutics for $10.25per share in cash. This all-cash transaction represents a premium of 40% to the…
Read More...

Artemis Therapeutics announced the appointment of Brian M. Culley, M.A., M.B.A. as its Chief Executive Officer. Mr. Culley is an entrepreneurial and innovative biotech executive with 25…
Read More...

Incyte Corporation and MacroGenics, Inc. announced that the companies have entered into an exclusive global collaboration and license agreement for MacroGenics’ MGA012, an…
Read More...